Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Saia Inc.

Start price
Target price
Perf. (%)
€204.00
05.04.22
€230.00
05.05.22
0.00%
06.05.22

Could be worthwhile Investment >10% per year
buy
Vertex Energy Inc.

Start price
Target price
Perf. (%)
€7.97
05.04.22
-
05.04.23
5.61%
05.04.23

buy
Energiekontor

Start price
Target price
Perf. (%)
€100.20
05.04.22
-
05.04.23
-26.35%
05.04.23

buy
Jenoptik AG

Start price
Target price
Perf. (%)
€26.38
04.04.22
-
04.04.25
10.24%
11.03.24

Could be worthwhile Investment >10% per year
buy
Jenoptik AG

Start price
Target price
Perf. (%)
€26.38
04.04.22
-
04.04.25
10.24%
11.03.24

Could be worthwhile Investment >10% per year
buy
SPI Energy Co Ltd ADR

Start price
Target price
Perf. (%)
€2.97
04.04.22
€4.00
04.04.23
-65.97%
05.04.23

Could be very worthwhile Investment >20% year
buy
Zeal Network SE

Start price
Target price
Perf. (%)
€35.60
04.04.22
-
04.04.23
-2.81%
05.04.23

buy
SPI Energy Co Ltd ADR

Start price
Target price
Perf. (%)
€3.59
04.04.22
-
04.04.23
-36.75%
16.04.22

Could be worthwhile Investment >10% per year
Good culture
Below average Marketposition
Few uniques
buy
First Majestic Silver Corp.

Start price
Target price
Perf. (%)
€12.37
04.04.22
-
04.04.23
4.66%
16.04.22

Undervalued
Could be very worthwhile Investment >20% year
Very Future proof/growth oriented business model
Top 10 in its market
21Vianet Group Inc. ADR

Start price
Target price
Perf. (%)
€5.55
03.04.22
-
03.04.23
-31.53%
04.04.23

Probably not worthwhile Investment
Clovis Oncology Inc.

Start price
Target price
Perf. (%)
€2.28
03.04.22
-
03.04.23
-98.20%
04.04.23

Probably not worthwhile Investment
buy
Axsome Therapeutics Inc

Start price
Target price
Perf. (%)
€40.88
03.04.22
-
03.04.23
39.43%
04.04.23

Could be worthwhile Investment >10% per year
buy
BeiGene Ltd ADR

Start price
Target price
Perf. (%)
€184.00
02.04.22
€200.00
02.04.23
-15.22%
16.04.22

Could be worthwhile Investment >10% per year
Top 10 in its market
Small cyclical dependencies
Future proof or reliable business model
ATOSS Software AG

Start price
Target price
Perf. (%)
€182.00
02.04.22
-
02.04.23
-8.57%
16.04.22

EBIT growth >5% per year expected
Below average Management
Little innovation
Higher risks for its business
buy
Dürr AG

Start price
Target price
Perf. (%)
€28.00
30.03.22
-
30.03.23
18.00%
31.03.23

buy
Pfeiffer Vacuum

Start price
Target price
Perf. (%)
€189.60
30.03.22
€240.00
30.03.23
-17.62%
31.03.23

Revenue growth >5% per year expected
Higher EBIT margin than peer group
EBIT growth >5% per year expected
Fair valuation
buy
Valneva SE

Start price
Target price
Perf. (%)
€15.60
30.03.22
-
30.03.23
-55.74%
20.11.22

Could be worthwhile Investment >10% per year
Very valuable balance sheet
buy
Aceragen Inc.

Start price
Target price
Perf. (%)
€8.06
29.03.22
€15.30
29.03.23
-17.24%
30.03.23

Could be worthwhile Investment >10% per year
Vertex Energy Inc.

Start price
Target price
Perf. (%)
€8.05
29.03.22
-
29.03.23
24.22%
01.04.22

Probably not worthwhile Investment
buy
iRhythm Technologies Inc

Start price
Target price
Perf. (%)
€137.00
29.03.22
-
29.03.23
-16.79%
29.03.23

Marathon Digital Holdings

Start price
Target price
Perf. (%)
€28.50
28.03.22
-
28.03.23
-8.07%
02.04.22

Risky Investment
Marubeni Corp

Start price
Target price
Perf. (%)
€11.05
28.03.22
-
28.03.23
-9.52%
12.04.22

Could be worthwhile Investment >10% per year
Revenue growth > 30% per year expected
Marubeni Corp

Start price
Target price
Perf. (%)
€11.05
28.03.22
-
28.03.23
-9.52%
12.04.22

Could be worthwhile Investment >10% per year
Revenue growth > 30% per year expected
Marubeni Corp

Start price
Target price
Perf. (%)
€11.05
28.03.22
-
28.03.23
-9.52%
12.04.22

Could be worthwhile Investment >10% per year
Revenue growth > 30% per year expected
Marubeni Corp

Start price
Target price
Perf. (%)
€11.05
28.03.22
-
28.03.23
-9.52%
12.04.22

Could be worthwhile Investment >10% per year
Revenue growth > 30% per year expected